PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 158 filers reported holding PRECIGEN INC in Q1 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $304,000 | -28.1% | 200,000 | 0.0% | 0.01% | -16.7% |
| Q3 2022 | $423,000 | +57.8% | 200,000 | 0.0% | 0.01% | +50.0% |
| Q2 2022 | $268,000 | -73.5% | 200,000 | -58.3% | 0.00% | -66.7% |
| Q1 2022 | $1,013,000 | +2202.3% | 480,000 | +3939.7% | 0.01% | – |
| Q4 2021 | $44,000 | -25.4% | 11,882 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $59,000 | -23.4% | 11,882 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $77,000 | -6.1% | 11,882 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $82,000 | -94.8% | 11,882 | -92.4% | 0.00% | -94.4% |
| Q4 2020 | $1,587,000 | +7113.6% | 155,419 | +2291.1% | 0.04% | +3500.0% |
| Q3 2020 | $22,000 | -29.0% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $31,000 | +40.9% | 6,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $22,000 | – | 6,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |